Influence of temporary nasal occlusion (tNO) on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia (HHT)

被引:0
作者
Kornelia E. C. Wirsching
Frank Haubner
Thomas S. Kühnel
机构
[1] University of Regensburg,Department of Otorhinolaryngology
来源
European Archives of Oto-Rhino-Laryngology | 2017年 / 274卷
关键词
Hereditary hemorrhagic telangiectasia; HHT; Temporary nasal occlusion; tNO; Nd:YAG laser therapy; Epistaxis;
D O I
暂无
中图分类号
学科分类号
摘要
The objective of the study was to evaluate the influence of temporary nasal occlusion (tNO) with hypoallergenic tape on the frequency and severity of epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT). This prospective observational study included 20 HHT patients who were undergoing Nd:YAG laser therapy at regular intervals. Over a 3-month period, laser therapy was supplemented by tNO with hypoallergenic tape for 5 h/day on average. On a 0–10 numeric rating scale, the patients reported significantly greater satisfaction in epistaxis terms after tNO treatment, with mean scores of 5 before and 7 after 3-month tNO (p = 0.05). The Epistaxis Severity Score also fell significantly from a median of 3.59–2.43 after 3-month tNO compared with laser therapy alone (p = 0.01). The patients’ hemoglobin levels remained stable during the study (median: 12.2 g/dL before tNO; median: 11.7 g/dL after tNO; p = 0.387). Overall, the present study confirms the positive influence of tNO on epistaxis in HHT patients and on subjective satisfaction. This simple and inexpensive strategy is therefore a helpful option, especially in addition to regular Nd:YAG laser therapy, and is recommended by the authors.
引用
收藏
页码:1891 / 1896
页数:5
相关论文
共 134 条
  • [1] Plauchu H(1989)Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population Am J Med Genet 32 291-297
  • [2] de Chadarévian JP(1997)A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia J Laryngol Otol 111 34-37
  • [3] Bideau A(2004)Mucocutaneous telangiectases of the head and neck in individuals with hereditary hemorrhagic telangiectasia—analysis of distribution and symptoms Eur J Dermatol 14 407-411
  • [4] Robert JM(1994)Modified Young’s procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia Laryngoscope 104 1174-1177
  • [5] Lennox PA(1967)Closure of the nostrils in atrophic rhinitis J Laryngol Otol 81 515-524
  • [6] Harries M(2010)An epistaxis severity score for hereditary hemorrhagic telangiectasia Laryngoscope 120 838-843
  • [7] Lund VJ(2016)Update on clinical strategies in hereditary hemorrhagic telangiectasia from an ENT point of view Clin Exp Otorhinolaryngol 19 508-513
  • [8] Howard DJ(2005)Clinical strategy in hereditary hemorrhagic telangiectasia Am J Rhinol 48 73-87
  • [9] Folz BJ(2011)International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia J Med Genet 131 535-539
  • [10] Lippert BM(2006)Recurrent nosebleeds in patients with hereditary hemorrhagic telangiectasia Dtsch Med Wochenschr 123 820-822